您的购物车当前为空
别名 NSC694621
NSC 694621是一种PCAF和组蛋白乙酰转移酶( histone acetyltransferase,HAT)抑制剂,与PCAF的活性位点Cys574形成共价键,从而不可逆地抑制其乙酰转移酶活性,能够抑制SK-N-SH 和HCT116细胞增殖,具有抗癌潜力。


为众多的药物研发团队赋能,
让新药发现更简单!
NSC 694621是一种PCAF和组蛋白乙酰转移酶( histone acetyltransferase,HAT)抑制剂,与PCAF的活性位点Cys574形成共价键,从而不可逆地抑制其乙酰转移酶活性,能够抑制SK-N-SH 和HCT116细胞增殖,具有抗癌潜力。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥ 497 | In Stock | |
| 5 mg | ¥ 828 | In Stock | |
| 10 mg | ¥ 1,270 | In Stock | |
| 25 mg | ¥ 2,150 | In Stock | |
| 50 mg | ¥ 3,180 | In Stock | |
| 100 mg | ¥ 4,680 | In Stock | |
| 200 mg | ¥ 6,670 | In Stock |
NSC 694621 相关产品
| 产品描述 | NSC 694621 is a PCAF and histone acetyltransferase (HAT) inhibitor that forms a covalent bond with Cys574, the active site of PCAF, thereby irreversibly inhibiting its acetyltransferase activity, and is able to inhibit the proliferation of SK-N-SH and HCT116 cells, which has anticancer potential. |
| 靶点活性 | PCAF (HAT) H3 (1–21): 5.19 μM, SK-N-SH neuroblastoma cells:19.2 ± 1.22 μM (GI₅₀), PCAF (HAT) H4 (2–24):1.59 μM |
| 体外活性 | NSC 694621 可抑制 PCAF HAT 活性,对 H3 的 IC₅₀ 为 5.19 μM,对 H4 为 1.59 μM,对 H4 的抑制更强 [1]。NSC 694621 在 SK-N-SH 神经母细胞瘤细胞中表现出中等抗增殖活性,GI₅₀ 为 19.2 ± 1.22 μM。在 HCT116 结直肠癌细胞中,25 μM 浓度下抑制率为 29% [1]。 |
| 别名 | NSC694621 |
| 分子量 | 258.3 |
| 分子式 | C13H10N2O2S |
| CAS No. | 104857-29-6 |
| Smiles | O=C1C2=CC=CN=C2SN1C3=CC=C(OC)C=C3 |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||
| 溶解度信息 | DMSO: 1 mg/mL (3.87 mM), Sonication and heating are recommended | ||||||||||
溶液配制表 | |||||||||||
DMSO
| |||||||||||
评论内容